Terence Gourlay
Research Subjects
Terence Gourlay has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
Ahmed Ajzan
Faculty of Medicine, Hammersmith Hospital Campus, Imperial College London, United Kingdom
1 shared publicationDominique Lacroix
Service de Chirurgie Cardiovasculaire, Hôpital Cardiologique, Lille, France
1 shared publicationGary Philips
‡University of Brighton, Brighton, United Kingdom
1 shared publicationGeorges Fayad
Service de Chirurgie Cardiovasculaire, Hôpital Cardiologique, Lille, France
1 shared publicationHenri Warembourg
Service de Chirurgie Cardiovasculaire, Hôpital Cardiologique, Lille, France
1 shared publicationJeremy S. F.R.C.S.(Plast.) Hurren
Department of Surgery (Qureshi)
1 shared publication
Latest Publications
- 1 March 2008
- Published by Wolters Kluwer Health in Plastic and Reconstructive Surgery
- Vol. 121 (3) , 132e-133e
Can Bipolar Diathermy Enhance Scoring in Otoplasty? An Ex Vivo Study
This paper discusses whether bipolar diathermy can enhance scoring in otoplasty. It was published in the 'Plastic and Reconstructive Surgery' journal in 2008
- 1 March 2008
- Published by Wolters Kluwer Health in Plastic and Reconstructive Surgery
- Vol. 121 (3) , 132e-133e
Can Bipolar Diathermy Enhance Scoring in Otoplasty? An Ex Vivo Study
This paper discusses whether bipolar diathermy can enhance scoring in otoplasty. It was published in the 'Plastic and Reconstructive Surgery' journal in 2008
- 1 March 2007
- Published by Wolters Kluwer Health in Annals of Plastic Surgery
- Vol. 58 (3) , 321-327
The Effectiveness of Scoring and Bipolar Diathermy on Ear Cartilage Behavior
A common unsatisfactory long-term outcome of otoplasty is undercorrection and residual deformity. Aggressive scoring with a scalpel blade can cause unattractive and painful ridging, especially in older patients with stiffer cartilage. We developed an ex vivo pig ear model to compare the effectiveness of bipolar diathermy with blade scoring for cartilage warping. Strips of cartilage harvested from Landrace pig ears were subjected to bipolar diathermy (group A), blade scoring (group B), and blade scoring combined with reverse-side bipolar diathermy (group C). The strip deflection and cartilage tension were measured for each group. No statistical difference (P ≤ 0.05) was detected between group A and group B for both outcomes. Scoring combined with bipolar diathermy resulted in highly significant increases in both deflection (P ≤ 4.69−6) and tension (P ≤ 2.9−4). In conclusion, bipolar diathermy and scoring are equally effective in warping cartilage. Scoring combined with bipolar diathermy is highly synergistic and produces more robust warping than scoring alone. This may help reduce both long- and short-term problems with undercorrection by allowing stronger conchal correction without producing the unattractive ridging that occurs with aggressive scoring.
- 1 March 2007
- Published by Wolters Kluwer Health in Annals of Plastic Surgery
- Vol. 58 (3) , 321-327
The Effectiveness of Scoring and Bipolar Diathermy on Ear Cartilage Behavior
A common unsatisfactory long-term outcome of otoplasty is undercorrection and residual deformity. Aggressive scoring with a scalpel blade can cause unattractive and painful ridging, especially in older patients with stiffer cartilage. We developed an ex vivo pig ear model to compare the effectiveness of bipolar diathermy with blade scoring for cartilage warping. Strips of cartilage harvested from Landrace pig ears were subjected to bipolar diathermy (group A), blade scoring (group B), and blade scoring combined with reverse-side bipolar diathermy (group C). The strip deflection and cartilage tension were measured for each group. No statistical difference (P ≤ 0.05) was detected between group A and group B for both outcomes. Scoring combined with bipolar diathermy resulted in highly significant increases in both deflection (P ≤ 4.69−6) and tension (P ≤ 2.9−4). In conclusion, bipolar diathermy and scoring are equally effective in warping cartilage. Scoring combined with bipolar diathermy is highly synergistic and produces more robust warping than scoring alone. This may help reduce both long- and short-term problems with undercorrection by allowing stronger conchal correction without producing the unattractive ridging that occurs with aggressive scoring.
- 31 August 2006
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 82 (2) , 672-678
Changes in Cerebral Vascular Reactivity Occur Early During Cardiopulmonary Bypass in the Rat
- 31 August 2006
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 82 (2) , 672-678
Changes in Cerebral Vascular Reactivity Occur Early During Cardiopulmonary Bypass in the Rat
- Open Access
- 15 June 2006
- Published by EDP Sciences in The Journal of ExtraCorporeal Technology
- Vol. 38 (2) , 116-121
Quantification of Fat Mobilization in Patients Undergoing Coronary Artery Revascularization Using Off-pump and On-pump Techniques
Fat mobilization during cardiopulmonary bypass (CPB) is a recognized risk of the procedure. Intravascular mobilization of fat emboli subsequent to CPB has been implicated in some of its recognized pathophysiologies, particularly with regard to cerebral embolic injury. The aim of this study was to investigate whether fat mobilization is still a real issue in modern perfusion practice and to determine whether off pump coronary artery bypass techniques minimize this risk. Thirty patients undergoing routine elective coronary artery bypass graft (CABG) surgery were divided into two groups. Group 1 patients underwent off pump coronary artery bypass (OPCAB) procedures, and group 2 underwent CABG supported with CPB. Blood samples were taken from the CPB patients at the beginning, middle, and end of the procedure, from the suction line, from the arterial line, and from the venous line for measurement of fat emboli present. Samples were taken at corresponding time-points from the OPCAB patients for similar measurements. Fat emboli were counted manually using Oil red O staining and light microscopy. The fat emboli were sized using calibrated microspheres as a visual size contrast. No fat emboli were observed in any of the blood samples taken from the OPCAB patients. There were fat emboli present in all samples taken during CPB from all sources. The count was highest in the suction system and lowest in the venous blood and tended to increase during CPB. There was an absence of large fat emboli in the venous blood, which tends to indicate that the larger fat emboli lodge in the microvasculature. OPCAB surgery eliminates the risk of fat embolization in patients undergoing coronary revascularization. The suction system is the major source of fat emboli during CPB, and despite the multiple filtration components of the CPB system, fat emboli of various and significant sizes do reach the patient. Fat embolization remains a risk in routine elective CABG surgery. Cardiotomy suction should be eliminated where possible.
- 15 June 2006
- Published by EDP Sciences in The Journal of ExtraCorporeal Technology
- Vol. 38 (2) , 116-121
Open AccessQuantification of Fat Mobilization in Patients Undergoing Coronary Artery Revascularization Using Off-pump and On-pump Techniques
Fat mobilization during cardiopulmonary bypass (CPB) is a recognized risk of the procedure. Intravascular mobilization of fat emboli subsequent to CPB has been implicated in some of its recognized pathophysiologies, particularly with regard to cerebral embolic injury. The aim of this study was to investigate whether fat mobilization is still a real issue in modern perfusion practice and to determine whether off pump coronary artery bypass techniques minimize this risk. Thirty patients undergoing routine elective coronary artery bypass graft (CABG) surgery were divided into two groups. Group 1 patients underwent off pump coronary artery bypass (OPCAB) procedures, and group 2 underwent CABG supported with CPB. Blood samples were taken from the CPB patients at the beginning, middle, and end of the procedure, from the suction line, from the arterial line, and from the venous line for measurement of fat emboli present. Samples were taken at corresponding time-points from the OPCAB patients for similar measurements. Fat emboli were counted manually using Oil red O staining and light microscopy. The fat emboli were sized using calibrated microspheres as a visual size contrast. No fat emboli were observed in any of the blood samples taken from the OPCAB patients. There were fat emboli present in all samples taken during CPB from all sources. The count was highest in the suction system and lowest in the venous blood and tended to increase during CPB. There was an absence of large fat emboli in the venous blood, which tends to indicate that the larger fat emboli lodge in the microvasculature. OPCAB surgery eliminates the risk of fat embolization in patients undergoing coronary revascularization. The suction system is the major source of fat emboli during CPB, and despite the multiple filtration components of the CPB system, fat emboli of various and significant sizes do reach the patient. Fat embolization remains a risk in routine elective CABG surgery. Cardiotomy suction should be eliminated where possible.
- 1 June 2006
- Published by Wolters Kluwer Health in Plastic and Reconstructive Surgery
- Vol. 117 (7) , 2269-2276
Assessment of the Risk of Systemic Fat Mobilization and Fat Embolism as a Consequence of Liposuction: Ex Vivo Study
Background: Adverse consequences of liposuction, including those associated with fat embolism, have been reported in the literature. Fat embolism syndrome after liposuction may be underestimated because of the unspecific nature of the symptoms. The aim of this study was to determine whether there is a generic risk of the generation of intravascular fat emboli as a consequence of liposuction. Methods: An animal study was conducted in which liposuction was performed on 10 Sprague-Dawley rats. The procedure was conducted with the animals under general anesthesia for 60 minutes, in a similar manner to that practiced clinically. Three blood samples were taken from each animal through a central line (one before liposuction and two at 30 and 60 minutes into liposuction) and examined for the presence of fat particles. The animals were then euthanized and the lungs and brain were removed for histological examination. In the control group, liposuction was not performed, but similar blood and histological samples were taken. Results: In the study group, stained fat particles were seen in all blood samples taken during liposuction but not in those taken before liposuction. The difference between the 30- and 60-minute samples and the preliposuction control ones was statistically significant (p < 0.001 minimum). The differences between the 30-minute and 60-minute samples were also statistically significant (p = 0.017), demonstrating that fat mobilization during liposuction is a cumulative process. Nothing of significance was seen in the blood samples of the control group. Lipid deposits were seen in the lungs of all study group animals but not in the control group. With one possible exception, no lipid deposits were confirmed in brain specimens. Conclusions: The authors’ experiments have demonstrated a significant risk of systemic fat mobilization and fat embolism after liposuction in the animal model. Further clinical investigation is required to evaluate the real clinical risk of this procedure from this perspective.
- 1 June 2006
- Published by Wolters Kluwer Health in Plastic and Reconstructive Surgery
- Vol. 117 (7) , 2269-2276
Assessment of the Risk of Systemic Fat Mobilization and Fat Embolism as a Consequence of Liposuction: Ex Vivo Study
Background: Adverse consequences of liposuction, including those associated with fat embolism, have been reported in the literature. Fat embolism syndrome after liposuction may be underestimated because of the unspecific nature of the symptoms. The aim of this study was to determine whether there is a generic risk of the generation of intravascular fat emboli as a consequence of liposuction. Methods: An animal study was conducted in which liposuction was performed on 10 Sprague-Dawley rats. The procedure was conducted with the animals under general anesthesia for 60 minutes, in a similar manner to that practiced clinically. Three blood samples were taken from each animal through a central line (one before liposuction and two at 30 and 60 minutes into liposuction) and examined for the presence of fat particles. The animals were then euthanized and the lungs and brain were removed for histological examination. In the control group, liposuction was not performed, but similar blood and histological samples were taken. Results: In the study group, stained fat particles were seen in all blood samples taken during liposuction but not in those taken before liposuction. The difference between the 30- and 60-minute samples and the preliposuction control ones was statistically significant (p < 0.001 minimum). The differences between the 30-minute and 60-minute samples were also statistically significant (p = 0.017), demonstrating that fat mobilization during liposuction is a cumulative process. Nothing of significance was seen in the blood samples of the control group. Lipid deposits were seen in the lungs of all study group animals but not in the control group. With one possible exception, no lipid deposits were confirmed in brain specimens. Conclusions: The authors’ experiments have demonstrated a significant risk of systemic fat mobilization and fat embolism after liposuction in the animal model. Further clinical investigation is required to evaluate the real clinical risk of this procedure from this perspective.
- 1 July 2003
- Published by SAGE Publications in Perfusion
- Vol. 18 (4) , 225-231
Does cardiopulmonary bypass still represent a good investment? The biomaterials perspective
Cardiopulmonary (CPB) bypass is 50 years old this year, and has undergone considerable change in that time, particularly with regard to developing technology. However, in recent years the routine application of CPB, as the treatment of choice for patients undergoing reparative heart surgery, has been challenged by new, evolving techniques, particularly Off-Pump Coronary Artery Bypass (OPCAB) and stenting. This paper considers whether CPB still represents a sound investment prospect, with particular emphasis on the biomaterial developments currently taking place. Whilst we accept that routine application of CPB is shrinking under pressure from less invasive techniques, we suggest that this may represent an opportunity to deliever a more highly evolved perfusion to the core of very sick and complex patients who may not be suitable candidates for OPCAB or stenting. These patients will benefit from the application of new technologies currently under development, such as smaller perfusion circuits, improved biomaterial surfaces, smart membranes, and biosensor technology, all aimed at making clinical perfusion a safer and more predictable procedure for the patient. All things conssidered, we feel that CPB, although shrinking in absolute size, still represents a good investment.
- 1 July 2003
- Published by SAGE Publications in Perfusion
- Vol. 18 (4) , 225-231
Does cardiopulmonary bypass still represent a good investment? The biomaterials perspective
Cardiopulmonary (CPB) bypass is 50 years old this year, and has undergone considerable change in that time, particularly with regard to developing technology. However, in recent years the routine application of CPB, as the treatment of choice for patients undergoing reparative heart surgery, has been challenged by new, evolving techniques, particularly Off-Pump Coronary Artery Bypass (OPCAB) and stenting. This paper considers whether CPB still represents a sound investment prospect, with particular emphasis on the biomaterial developments currently taking place. Whilst we accept that routine application of CPB is shrinking under pressure from less invasive techniques, we suggest that this may represent an opportunity to deliever a more highly evolved perfusion to the core of very sick and complex patients who may not be suitable candidates for OPCAB or stenting. These patients will benefit from the application of new technologies currently under development, such as smaller perfusion circuits, improved biomaterial surfaces, smart membranes, and biosensor technology, all aimed at making clinical perfusion a safer and more predictable procedure for the patient. All things conssidered, we feel that CPB, although shrinking in absolute size, still represents a good investment.